Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William J. Gradishar, MD
Robert H. Lurie Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northwest Alabama Cancer Center, Pc - Muscle Shoals
Muscle Shoals, Alabama, United States
- Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas, United States
- Pacific Cancer Medical Center, Incorporated
Anaheim, California, United States
- Pacific Coast Hematology/oncology Medical Group, Incorporated
Fountain Valley, California, United States
- Desert Hematology-Oncology Medical Group, Incorporated
Rancho Mirage, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Cancer Prevention and Treatment Center at Dominican and Watsonville Community Hospital
Soquel, California, United States
- Facility name not stated
St. Helena, California, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, United States
- Medical Oncology and Hematology, Pc at Harold Leever Cancer Center
Waterbury, Connecticut, United States
- George Washington University Cancer Institute
Washington D.C., District of Columbia, United States
- Pasco Hernando Oncology Associates, Pa - Brooksville
Brooksville, Florida, United States
- Pasco Hernando Oncology Associates, Pa - New Port Richey
New Port Richey, Florida, United States
- Northeast Georgia Cancer Care, Llc - Medical Oncology
Athens, Georgia, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- Hematology-Oncology Associates of Illinois
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Cancer Institute at Alexian Brothers
Elk Grove Village, Illinois, United States
- Medical and Surgical Specialists, Llc
Galesburg, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Midwest Center for Hematology/oncology
Joliet, Illinois, United States
- Kellogg Cancer Care Center
Oak Park, Illinois, United States
- Hematology/oncology of the North Shore at Gross Point Medical Center
Skokie, Illinois, United States
- Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
- Family Medicine of Vincennes Clinical Trial Center
Vincennes, Indiana, United States
- Kentuckiana Cancer Institute, Pllc
Louisville, Kentucky, United States
- Mary Bird Perkins Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
Columbia, Missouri, United States
- Nebraska Hematology-Oncology, Pc
Lincoln, Nebraska, United States
- Essex Oncology of North Jersey
Belleville, New Jersey, United States
- Sussex County Medical Associates - Sparta
Sparta, New Jersey, United States
- Piedmont Hematology-Oncology Associates
Winston-Salem, North Carolina, United States
- Tri-County Hematology/oncology Associates, Incorporated
Canton, Ohio, United States
- Hematology Oncology Consultants, Incorporated
Columbus, Ohio, United States
- North Coast Cancer Care, Incorporated
Sandusky, Ohio, United States
- Hematology and Oncology Associates of Rhode Island
Cranston, Rhode Island, United States
- West Clinic - East Memphis
Memphis, Tennessee, United States
- Patients' Comprehensive Cancer Center - Carrollton
Carrollton, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 31 Dec 2020
- Completion
- 31 Dec 2022
- Last update posted
- 3 May 2019
- Registered enrollment
- 180
- Registry id
- NCT00499525
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.